Skip to main content
SpringerLink
Log in

Examining US cancer drug prices per survival gain 1995−2017

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chen AJ, et al. Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017. Value in Health : 23 Sep 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.08.005

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Examining US cancer drug prices per survival gain 1995−2017. PharmacoEcon Outcomes News 838, 10 (2019). https://doi.org/10.1007/s40274-019-6255-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6255-1

Search

Navigation